Winebrenner Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$384K Buy
993
+2
+0.2% +$742 0.23% 102
2026
Q1
$290K Hold
991
0.19% 112
2025
Q4
$347K Buy
+991
New +$335K 0.23% 100
2025
Q2
Sell
-508
Closed -$221K 129
2025
Q1
$221K Buy
+508
New +$204K 0.2% 114

Other funds holding ELV

Winebrenner Capital Management's ELV Position: Q2 2026 in Review

Winebrenner Capital Management increased its Elevance Health (ELV) stake by 0.2% in Q2 2026, buying an estimated $742 and bringing the position to 993 shares worth $384K. The position accounts for 0.23% of the portfolio, ranked #102.

Winebrenner Capital Management first reported a position in ELV in Q1 2025 and has held it in 4 quarters since. 222 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Winebrenner Capital Management held 993 shares of Elevance Health worth $384K as of Q2 2026.
  • Winebrenner Capital Management bought 2 Elevance Health shares in Q2 2026, an estimated $742.
  • Elevance Health made up 0.23% of Winebrenner Capital Management's portfolio in Q2 2026, its #102 holding.
  • Winebrenner Capital Management first reported a position in Elevance Health in Q1 2025 and has held it in 4 quarters since.
  • 222 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Winebrenner Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.